...

Module

Faculty Responses to Additional Questions on the Use of Integrase Inhibitors in Clinical Practice

Source: Answering the Questions: Clinical Considerations in the Use of Integrase Inhibitors

Faculty Responses to Additional Questions on the Use of Integrase Inhibitors in Clinical Practice


Faculty:

William G. Powderly, MDPaul E. Sax, MDJonathan M. Schapiro, MD
  • William G. Powderly, MD
  • Paul E. Sax, MD
  • Jonathan M. Schapiro, MD

CREDIT INFORMATION

Release Date: 12/10/09

Expiration Date: 12/09/10


Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recount drug-drug interactions associated with the use of raltegravir
  • Describe adverse events associated with integrase inhibitors
  • Discuss the feasibility of using raltegravir in special populations, such as pediatric patients and pregnant women
  • Recount data on the investigational integrase inhibitor S/GSK1349572

Topics covered include:

  • Use of Integrase Inhibitors as First-line Therapy
  • Switching Virologically Suppressed Patients
  • Resistance to Integrase Inhibitors
  • Drug-Drug Interactions
  • Adverse Events
  • Special Populations
  • Investigational Integrase Inhibitors

Abstract
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.